Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunotherapies for Hodgkin's lymphoma.
Kasamon YL, Ambinder RF. Kasamon YL, et al. Crit Rev Oncol Hematol. 2008 May;66(2):135-44. doi: 10.1016/j.critrevonc.2007.10.001. Epub 2007 Nov 19. Crit Rev Oncol Hematol. 2008. PMID: 18023356 Free PMC article. Review.
Phase II study of risk-adapted therapy of newly diagnosed, aggressive non-Hodgkin lymphoma based on midtreatment FDG-PET scanning.
Kasamon YL, Wahl RL, Ziessman HA, Blackford AL, Goodman SN, Fidyk CA, Rogers KM, Bolaños-Meade J, Borowitz MJ, Ambinder RF, Jones RJ, Swinnen LJ. Kasamon YL, et al. Biol Blood Marrow Transplant. 2009 Feb;15(2):242-8. doi: 10.1016/j.bbmt.2008.11.026. Biol Blood Marrow Transplant. 2009. PMID: 19167684 Free PMC article. Clinical Trial.
Circulating clonotypic B cells in classic Hodgkin lymphoma.
Jones RJ, Gocke CD, Kasamon YL, Miller CB, Perkins B, Barber JP, Vala MS, Gerber JM, Gellert LL, Siedner M, Lemas MV, Brennan S, Ambinder RF, Matsui W. Jones RJ, et al. Among authors: kasamon yl. Blood. 2009 Jun 4;113(23):5920-6. doi: 10.1182/blood-2008-11-189688. Epub 2009 Feb 2. Blood. 2009. PMID: 19188663 Free PMC article.
Phase 2 study of rituximab-ABVD in classical Hodgkin lymphoma.
Kasamon YL, Jacene HA, Gocke CD, Swinnen LJ, Gladstone DE, Perkins B, Link BK, Popplewell LL, Habermann TM, Herman JM, Matsui WH, Jones RJ, Ambinder RF. Kasamon YL, et al. Blood. 2012 May 3;119(18):4129-32. doi: 10.1182/blood-2012-01-402792. Epub 2012 Feb 16. Blood. 2012. PMID: 22343727 Free PMC article. Clinical Trial.
AIDS-related primary central nervous system lymphoma.
Kasamon YL, Ambinder RF. Kasamon YL, et al. Hematol Oncol Clin North Am. 2005 Aug;19(4):665-87, vi-vii. doi: 10.1016/j.hoc.2005.05.004. Hematol Oncol Clin North Am. 2005. PMID: 16083829 Review.
Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.
Bolaños-Meade J, Luznik L, Muth M, Matsui WH, Huff CA, Smith BD, Levy MY, Kasamon YL, Swinnen LJ, Powell JD, Brodsky RA, Ambinder RF, Jones RJ, Fuchs EJ. Bolaños-Meade J, et al. Among authors: kasamon yl. Bone Marrow Transplant. 2009 Mar;43(6):477-80. doi: 10.1038/bmt.2008.353. Epub 2008 Nov 3. Bone Marrow Transplant. 2009. PMID: 18978825 Free PMC article.
Immunologic recovery following autologous stem-cell transplantation with pre- and posttransplantation rituximab for low-grade or mantle cell lymphoma.
Kasamon YL, Jones RJ, Brodsky RA, Fuchs EJ, Matsui W, Luznik L, Powell JD, Blackford AL, Goodrich A, Gocke CD, Abrams RA, Ambinder RF, Flinn IW. Kasamon YL, et al. Ann Oncol. 2010 Jun;21(6):1203-1210. doi: 10.1093/annonc/mdp484. Epub 2009 Oct 30. Ann Oncol. 2010. PMID: 19880437 Free PMC article. Clinical Trial.
High-dose cyclophosphamide and rituximab without stem cell transplant: a feasibility study for low grade B-cell, transformed and mantle cell lymphomas.
Gladstone DE, Bolaños-Meade J, Huff CA, Zahurak M, Flinn I, Borrello I, Luznik L, Fuchs E, Kasamon Y, Matsui W, Powell J, Levitsky H, Brodsky RA, Ambinder R, Jones RJ, Swinnen LJ. Gladstone DE, et al. Leuk Lymphoma. 2011 Nov;52(11):2076-81. doi: 10.3109/10428194.2011.594191. Epub 2011 Jul 14. Leuk Lymphoma. 2011. PMID: 21756035 Free PMC article. Clinical Trial.
Induction of autologous graft-versus-host disease: results of a randomized prospective clinical trial in patients with poor risk lymphoma.
Bolaños-Meade J, Garrett-Mayer E, Luznik L, Anders V, Webb J, Fuchs EJ, Huff CA, Matsui W, Borrello IM, Brodsky R, Kasamon YL, Swinnen LJ, Flinn IW, Ambinder RF, Jones RJ, Hess AD, Vogelsang GB. Bolaños-Meade J, et al. Among authors: kasamon yl. Biol Blood Marrow Transplant. 2007 Oct;13(10):1185-91. doi: 10.1016/j.bbmt.2007.06.011. Epub 2007 Aug 3. Biol Blood Marrow Transplant. 2007. PMID: 17889355 Free PMC article. Clinical Trial.
82 results